Literature DB >> 29197065

Exosomes from heat-stressed tumour cells inhibit tumour growth by converting regulatory T cells to Th17 cells via IL-6.

Danfeng Guo1, Yinghu Chen2, Shoujie Wang1, Lei Yu3, Yingying Shen1, Haijun Zhong4, Yunshan Yang4.   

Abstract

Exosomes derived from heat-stressed tumour cells (HS-TEXs), which contain abundant heat shock protein (HSP) 70, strongly induce antitumour immune responses. HSP70-induced interleukin (IL)-6 promotes IL-17 expression and causes rejection of established prostate tumours. However, it remains unclear whether HS-TEXs exhibit antitumour effects by converting regulatory T cells (Tregs ) into T helper type 17 (Th17) cells. In this study, we found that compared with TEXs, HS-TEXs were more potent in stimulating secretion of IL-6 from dendritic cells. In vitro, IL-6 blocked tumour cell-derived transforming growth factor beta 1-induced Treg differentiation and promoted Th17 cell differentiation. HS-TEXs exerted strong antitumour effects, converting Tregs into Th17 cells with high efficiency, a process that was entirely dependent upon IL-6. Neutralization of IL-17 completely abolished the antitumour effect of TEXs, but only partially inhibited that of HS-TEXs. In addition, we found higher levels of IL-6 and IL-17 in serum from tumour patients treated with hyperthermia, and an increase in Th17 cells and a decrease in Tregs was detected in peripheral blood mononuclear cells isolated from these patients after hyperthermia. Therefore, our results demonstrate that HS-TEXs possess a powerful capacity to convert immunosuppressive Tregs into Th17 cells via IL-6, which contributes to their potent antitumour effect.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  IL-6; Th17; Tregs; exosomes; heat stress

Mesh:

Substances:

Year:  2018        PMID: 29197065      PMCID: PMC5904701          DOI: 10.1111/imm.12874

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  29 in total

1.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

2.  Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes.

Authors:  L Zitvogel; A Regnault; A Lozier; J Wolfers; C Flament; D Tenza; P Ricciardi-Castagnoli; G Raposo; S Amigorena
Journal:  Nat Med       Date:  1998-05       Impact factor: 53.440

3.  Chemokine-containing exosomes are released from heat-stressed tumor cells via lipid raft-dependent pathway and act as efficient tumor vaccine.

Authors:  Taoyong Chen; Jun Guo; Mingjin Yang; Xuhui Zhu; Xuetao Cao
Journal:  J Immunol       Date:  2011-01-17       Impact factor: 5.422

4.  Ag-presenting CpG-activated pDCs prime Th17 cells that induce tumor regression.

Authors:  Leslie Guéry; Juan Dubrot; Carla Lippens; Dale Brighouse; Pauline Malinge; Magali Irla; Caroline Pot; Walter Reith; Jean-Marc Waldburger; Stéphanie Hugues
Journal:  Cancer Res       Date:  2014-09-24       Impact factor: 12.701

5.  Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming.

Authors:  J Wolfers; A Lozier; G Raposo; A Regnault; C Théry; C Masurier; C Flament; S Pouzieux; F Faure; T Tursz; E Angevin; S Amigorena; L Zitvogel
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

6.  Th17 and Th17-stimulated CD8⁺ T cells play a distinct role in Th17-induced preventive and therapeutic antitumor immunity.

Authors:  Manjunatha Ankathatti Munegowda; Yulin Deng; Sean J Mulligan; Jim Xiang
Journal:  Cancer Immunol Immunother       Date:  2011-06-10       Impact factor: 6.968

Review 7.  Interaction between tumor and immune system: the role of tumor cell biology.

Authors:  N M Berezhnaya
Journal:  Exp Oncol       Date:  2010-09

Review 8.  Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens.

Authors:  Meredith M Curtis; Sing Sing Way
Journal:  Immunology       Date:  2009-02       Impact factor: 7.397

Review 9.  The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non-Small Cell Lung Cancer.

Authors:  Roy M Bremnes; Lill-Tove Busund; Thomas L Kilvær; Sigve Andersen; Elin Richardsen; Erna Elise Paulsen; Sigurd Hald; Mehrdad Rakaee Khanehkenari; Wendy A Cooper; Steven C Kao; Tom Dønnem
Journal:  J Thorac Oncol       Date:  2016-02-01       Impact factor: 15.609

10.  Induction of hsp70-mediated Th17 autoimmunity can be exploited as immunotherapy for metastatic prostate cancer.

Authors:  Timothy Kottke; Luis Sanchez-Perez; Rosa Maria Diaz; Jill Thompson; Heung Chong; Kevin Harrington; Stuart K Calderwood; Jose Pulido; Nick Georgopoulos; Peter Selby; Alan Melcher; Richard Vile
Journal:  Cancer Res       Date:  2007-12-15       Impact factor: 12.701

View more
  31 in total

1.  Autotaxin-Lysophosphatidic Acid Axis Blockade Improves Inflammation by Regulating Th17 Cell Differentiation in DSS-Induced Chronic Colitis Mice.

Authors:  Ya-Lan Dong; Xue-Yun Duan; Yu-Jin Liu; Heng Fan; Meng Xu; Qian-Yun Chen; Zhen Nan; Hui Wu; Shuang-Jiao Deng
Journal:  Inflammation       Date:  2019-10       Impact factor: 4.092

Review 2.  Possible roles of exosomal miRNAs in the pathogenesis of oral lichen planus.

Authors:  Congcong Li; Hong He; Jiaqin Wang; Xinyu Xia; Mengyun Zhang; Qingzhu Wu
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

Review 3.  Role of Laser Interstitial Thermal Therapy in the Management of Primary and Metastatic Brain Tumors.

Authors:  Kaitlyn Melnick; David Shin; Farhad Dastmalchi; Zain Kabeer; Maryam Rahman; David Tran; Ashley Ghiaseddin
Journal:  Curr Treat Options Oncol       Date:  2021-10-23

4.  Recirculating IL-1R2+ Tregs fine-tune intrathymic Treg development under inflammatory conditions.

Authors:  Eirini Nikolouli; Yassin Elfaki; Susanne Herppich; Carsten Schelmbauer; Michael Delacher; Christine Falk; Ilgiz A Mufazalov; Ari Waisman; Markus Feuerer; Jochen Huehn
Journal:  Cell Mol Immunol       Date:  2020-01-27       Impact factor: 11.530

5.  Exosomes derived from mesenchymal stem cells regulate Treg/Th17 balance in aplastic anemia by transferring miR-23a-3p.

Authors:  Qing-Zhao Shi; Hong-Mei Yu; Hong-Mei Chen; Miao Liu; Xue Cheng
Journal:  Clin Exp Med       Date:  2021-03-29       Impact factor: 3.984

Review 6.  Extracellular vesicles in immunomodulation and tumor progression.

Authors:  Carolyn Marar; Bartholomew Starich; Denis Wirtz
Journal:  Nat Immunol       Date:  2021-03-22       Impact factor: 31.250

Review 7.  A Challenge to Aging Society by microRNA in Extracellular Vesicles: microRNA in Extracellular Vesicles as Promising Biomarkers and Novel Therapeutic Targets in Multiple Myeloma.

Authors:  Tomofumi Yamamoto; Nobuyoshi Kosaka; Yutaka Hattori; Takahiro Ochiya
Journal:  J Clin Med       Date:  2018-03-12       Impact factor: 4.241

8.  Exosomes released by breast cancer cells under mild hyperthermic stress possess immunogenic potential and modulate polarization in vitro in macrophages.

Authors:  Kacoli Sen; Austin E F Sheppe; Ishita Singh; Winnie W Hui; Mariola J Edelmann; Carlos Rinaldi
Journal:  Int J Hyperthermia       Date:  2020       Impact factor: 3.914

Review 9.  Role of Extracellular Vesicles (EVs) in Cell Stress Response and Resistance to Cancer Therapy.

Authors:  Clodagh P O'Neill; Katie E Gilligan; Róisín M Dwyer
Journal:  Cancers (Basel)       Date:  2019-01-24       Impact factor: 6.639

Review 10.  Role of Extracellular Vesicles in Compromising Cellular Resilience to Environmental Stressors.

Authors:  Mona G Alharbi; Seok Hee Lee; Aaser M Abdelazim; Islam M Saadeldin; Mosleh M Abomughaid
Journal:  Biomed Res Int       Date:  2021-07-20       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.